0001213900-17-013093.txt : 20171211 0001213900-17-013093.hdr.sgml : 20171211 20171211161837 ACCESSION NUMBER: 0001213900-17-013093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171207 FILED AS OF DATE: 20171211 DATE AS OF CHANGE: 20171211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Straube Richard CENTRAL INDEX KEY: 0001595197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 171249681 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE, SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 4 1 f4120717straube_soligenix.xml OWNERSHIP DOCUMENT X0306 4 2017-12-07 0 0000812796 SOLIGENIX, INC. SNGX 0001595197 Straube Richard 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540 0 1 0 0 SVP and CMO Option (Right to Buy) 2.01 2017-12-07 4 A 0 35000 0 A 2017-12-07 2027-12-06 Common Stock 35000 35000 D The stock option vested immediately as to 8,750 shares and vests as to the remainder at a rate of 2,187.5 of the shares on each three (3) month anniversary of December 7, 2017. /s/ Richard Straube 2017-12-11